Ruthenium anticancer drugs

Met Ions Biol Syst. 2004:42:323-51.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cell Cycle / drug effects
  • Dimethyl Sulfoxide / analogs & derivatives*
  • Dimethyl Sulfoxide / chemistry
  • Humans
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Neoplasm Invasiveness / prevention & control
  • Neoplasm Metastasis / prevention & control
  • Neoplasms / pathology
  • Organometallic Compounds / chemistry
  • Ruthenium Compounds / chemical synthesis
  • Ruthenium Compounds / chemistry
  • Ruthenium Compounds / therapeutic use*

Substances

  • Antineoplastic Agents
  • Organometallic Compounds
  • Ruthenium Compounds
  • imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III)
  • Mitogen-Activated Protein Kinases
  • Dimethyl Sulfoxide